MYDA Advisors LLC - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTAC and the CUSIP is 58507N105. A total of 10 filers reported holding MEDTECH ACQUISITION CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MYDA Advisors LLC ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q3 2022$2,681,000
+0.9%
270,0000.0%1.26%
+69.4%
Q2 2022$2,658,000
-9.6%
270,000
-10.0%
0.74%
-36.0%
Q1 2022$2,940,000
-26.2%
300,000
-25.6%
1.16%
+9.3%
Q4 2021$3,982,000
-0.5%
403,0700.0%1.06%
-5.2%
Q3 2021$4,002,000
+2.4%
403,0700.0%1.12%
+14.9%
Q2 2021$3,910,000
+99.3%
403,070
+98.5%
0.98%
+79.2%
Q1 2021$1,962,000203,0700.54%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q4 2022
NameSharesValueWeighting ↓
MYDA Advisors LLC 403,070$3,910,0000.98%
Park West Asset Management LLC 1,250,000$12,125,0000.34%
SPRING CREEK CAPITAL LLC 503,600$4,885,0000.24%
ARISTEIA CAPITAL, L.L.C. 1,153,485$11,189,0000.22%
CVI Holdings, LLC 250,000$2,425,0000.16%
Context Capital Management, LLC 174,065$1,688,0000.16%
K.J. Harrison & Partners Inc 140,000$1,359,0000.14%
Radcliffe Capital Management, L.P. 414,584$4,021,0000.13%
Omni Partners US LLC 220,971$2,143,0000.09%
Vestcor Inc 276,074$2,694,0000.09%
View complete list of MEDTECH ACQUISITION CORP shareholders